Clinical Trial
doi: 10.1080/09540128908260251.
Treatment dilemmas for HIV infected haemophiliacs
Affiliations
- PMID: 2488281
- DOI: 10.1080/09540128908260251
Item in Clipboard
Clinical Trial
Treatment dilemmas for HIV infected haemophiliacs
AIDS Care.
1989.
Abstract
A description of a structured group, held for anti-HIV positive haemophiliacs and their relatives, to discuss the implications of participating in the MRC/INSERM double-blind control trial of zidovudine is given. The group discussion is used to define, evaluate and rank the many treatment dilemmas inherent in participating in this drug trial.
Similar articles
-
Treating HIV positive haemophiliacs with zidovudine.BMJ. 1988 Dec 17;297(6663):1608-9. doi: 10.1136/bmj.297.6663.1608-b. BMJ. 1988. PMID: 3147094 Free PMC article. No abstract available.
-
Treating HIV positive haemophiliacs with zidovudine.BMJ. 1988 Nov 19;297(6659):1331. doi: 10.1136/bmj.297.6659.1331. BMJ. 1988. PMID: 3144380 Free PMC article. No abstract available.
-
Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.Antivir Ther. 1997 Dec;2(4):229-36. Antivir Ther. 1997. PMID: 11327442 Clinical Trial.
-
Zidovudine in symptomless HIV infection.Lancet. 1989 Feb 25;1(8635):415-6. Lancet. 1989. PMID: 2563790 Review. No abstract available.
-
Are HIV-1 seropositive subjects submitted to one of the innumerable AZT randomized double-blind trials, definitively victims of cross and/or common resistance to all virostatics, even in combinations?Biomed Pharmacother. 1994;48(2):49-50. doi: 10.1016/0753-3322(94)90074-4. Biomed Pharmacother. 1994. PMID: 7919104 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
